Trial Profile
Clinical outcome with long-term bisphosphonate therapy in Paget's disease of Bone: The PRISM-EZ study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2014
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Osteitis deformans
- Focus Therapeutic Use
- Acronyms PRISM-EZ
- 05 May 2014 New trial record